Systemic Use of Arnica Montana for the Reduction of Postsurgical Sequels following Extraction of Impacted Mandibular 3^rd Molars: A Pilot Study

Table 2

Collected assessment parameters by phone call from all study subjects at Days 2 and 4.

	Day 2			Day 4
	AM group (n = 22)	Control group (n = 8)	values	AM group (n = 22)	Control group (n = 8)	values
Bleeding
None	16 (72.7%)	1 (12.5%)	0.004	22 (100%)	8 (100%)	NA
Grade 1	4 (18.2%)	6 (75.0%)		0	0
Grade 2	2 (9.1%)	1 (12.5%)		0	0
Grade 3	0	0		0	0
Swelling (edema)
None	6 (27.3%)	1 (12.5%)	0.085	7 (31.8%)	1 (12.5%)	0.027
Mild	12 (54.5%)	2 (25.0%)		12 (54.5%)	2 (25.0%)
Moderate	3 (13.6%)	5 (62.5%)		2 (9.1%)	1 (12.5%)
Severe	1 (4.5%)	0		1 (4.5%)	4 (50.0%)
Extraoral bruising
None	20 (90.9%)	4 (50.0%)	0.029	16 (72.2%)	5 (62.5%)	0.526
Mild	2 (9.1%)	4 (50.0%)		3 (13.6%)	1 (12.5%)
Moderate	0	0		3 (13.6%)	1 (12.5%)
Severe	0	0		0	1 (12.5%)
Limited mouth opening
None	5 (22.7%)	1 (12.5%)	0.016	7 (31.8%)	1 (12.5%)	0.123
Mild	12 (54.5%)	2 (25.0%)		11 (50.0%)	2 (25.0%)
Moderate	4 (18.2%)	5 (62.5%)		3 (13.6%)	3 (37.5%)
Severe	1 (4.5%)	0		1 (4.5%)	2 (25.0%)

Statistically significant.